Breast cancer survivor offers wisdom at Faulkner satellite center
Call 877-422-3324 today to make an appointment
Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.
Can’t get to Boston? Explore our Online Second Opinion service to get expert advice from Dana-Farber oncologists.
Toll-Free Number866-408-DFCI (3324)
Discover the ways to give and how to get involved to support Dana-Farber.
Poet Richard Fox gains insight – and material – through cancer treatment
A family faces cancer in an unfamiliar city – with help
Choosing mastectomy or not: Studying young women's surgical choices
Jeff's targeted therapy has kept his advanced lung cancer at bay.
Dana-Farber Cancer Institute applauds the decision by CVS Caremark to stop sales of all cigarettes and tobacco products by October. There is probably no other single step that CVS could take that would go as far to promote the health and well-being of its customers.
Tobacco use is the leading cause of preventable illness and death in the United States. Cigarette smoking is responsible for an estimated 443,000 deaths each year, including 49,000 deaths from exposure to secondhand smoke, according to the National Cancer Institute. Many of those deaths are from lung cancer, but smoking is also linked to cancers of the throat, mouth, esophagus, pancreas, kidney, bladder, and cervix, as well as acute myeloid leukemia.
As news reports have indicated, CVS is giving up a substantial revenue stream by taking this action. Fortunately, the benefits of reducing tobacco availability — in fewer doctor's visits, fewer days of work lost to illness, less loss of life and a generally healthier population — far outweigh any calculation of dollars and cents.
This step, by the nation's second-largest pharmacy chain, sends a powerful signal that tobacco products have no place at a retail organization dedicated to health. We hope that other retailers will see the enormous contribution that they could make to the nation's health if they were to join CVS in ridding their shelves of these products.
Edward J. Benz, Jr., MDPresident and Chief Executive OfficerDana-Farber Cancer Institute